The compounds in this study were bound to dihydrofolate reductase (DHFR), a protein that was chosen based on previous evidence showing that its inhibition is important in the development of anti-cancer drugs [62] or to glutathione reductase, a major antioxidant enzyme, which is a target for some anti-cancer agents [63]. This evidence concerns the gene GSR and cancer.